Article Versions Notes

Blanchette P, Sivajohanathan D, Bartlett J, Eisen A, Feilotter H, Pezo R, Turashvili G, Williams P. Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline. Current Oncology. 2022; 29(4):2599-2615. https://doi.org/10.3390/curroncol29040213

Blanchette, Phillip, Duvaraga Sivajohanathan, John Bartlett, Andrea Eisen, Harriet Feilotter, Rossanna Pezo, Gulisa Turashvili, and Phillip Williams. 2022. "Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline" Current Oncology 29, no. 4: 2599-2615. https://doi.org/10.3390/curroncol29040213

Blanchette, P., Sivajohanathan, D., Bartlett, J., Eisen, A., Feilotter, H., Pezo, R., Turashvili, G., & Williams, P. (2022). Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline. Current Oncology, 29(4), 2599-2615. https://doi.org/10.3390/curroncol29040213